Keep up to date with the latest news delivered direct to your Inbox.
VIDEO: Breast Cancer Drug 'Too Expensive' For NHS
6:09am 8th August 2014
(Updated 6:09am 8th August 2014)
A life-extending breast cancer drug trialled in Cornwall has been rejected for routine use by the NHS because it is "too expensive".
The National Institute for Health and Care Excellence (Nice) has issued a final draft blaming the high price for making it "impossible to recommend".
The drug, Kadcyla, is known to increase life expectancy by an average of around six months, with minimum side effects.
It treats people with HER2-positive breast cancer that has spread to other parts of the body.
Kim Mawby, 45, has been trialling the drug for three years after being diagnosed with breast cancer.
She was initially given six months to live but now lives a normal life with her husband and three children.
"I think it costs about £6,000 pounds a month. A lot of people are going to say that's too much money but I don't think you can put a price on someone's life.
"When I wake up I do feel incredibly lucky that I am still here, that I am able to just get up and go to work, see the kids off to school.
"I do sit back and think 'wow, if it wasn't for this drug I wouldn't be watching (my son) going to school on his first day.'"
Sir Andrew Dillon, Chief Executive of Nice, says the cost of the drug works out at £90,000 per patient, per year.
"This drug is so expensive that it's way beyond even that additional flexibility that we can offer.
"I can't negotiate the price with the manufacturer. It's entirely in Roche's hands, the manufacturer's hands, now. They know what they need to do."
However, Roche says the price reflects the value it provides to patients.
Jennifer Cozzone, from Roche, told Sky News that Nice is the first organisation to reject the drug, demonstrating a system in the UK that is broken.
"Every other country, including countries nearby like Norway or Sweden or Switzerland, who have very similar economies to ours, have considered Kadcyla to be good value for money and made it available routinely at very similar prices to what we're talking about here."
Nice says other countries have different arrangements for funding pharmaceuticals.
Kadcyla is available to some patients in the UK through the Cancer Drugs Fund but Nice says that is not a "long term mechanism".
A Department of Health spokesperson said: "Nice is an independent expert body that is responsible for evaluating what drugs should be available from the NHS, taking into account cost, demand and effectiveness.
"Kadcyla will still be available to patients through the Cancer Drugs Fund if their doctor thinks it is right for them and we remain open to discussions with the manufacturer about the price of Kadcyla to the NHS."
6:09am 8th August 2014
Share This StoryTweet
WATCH: The Cornish Women 'Forgetting' To Check For Breast Cancer
New stats show it is almost half
VIDEO: Rare Footage Of Dolphins Attacking Porpoise In Cornwall
The attack happened just outside Newlyn Harbour
Job Losses At Building Supplies Firm With Branches Across Cornwall
We do not know which Travis Perkins sites will be affected
Pensioner Dies After A30 Crash
Police say the 84 year old's car hit the central reservation at Launceston
BREAKING: Carharrack Woman Found Guilty Of Murder
Cornwall News: 96 year old Gladys Rowe died in a fire at a Truro care home
Theresa May 'objects to attempts to sideline UK at EU summit'
National News: The Prime Minister objected to attempts to sideline the UK almost as soon as her debut EU summit began, Sky News understands.
Business Cornwall News - Friday, 18th December 2015
Business Cornwall News: Cornwall is spearheading reform of the Uk’s business licensing laws following a a year-long project.
Colin Firth in negotiations to star in Mary Poppins sequel
Showbiz News: Colin Firth could join Emily Blunt and Meryl Streep in Disney’s Mary Poppins sequel.
The road to Mosul: 'The Humvee we parked beside disappeared in a mushroom cloud'
World News: I felt the blast from an enormous explosion and spun round.
British Cycling chief executive Ian Drake to stand down
Sports News: The chief executive of British Cycling Ian Drake is to step down.
Shark-cage diver 'reborn' after close encounter with great white
Strange News: A man who survived a face to face encounter with a great white shark says he feels "reborn" after the terrifying incident.